Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004303728 | SCV003965157 | uncertain significance | not specified | 2023-03-20 | criteria provided, single submitter | clinical testing | The c.1690C>T (p.R564W) alteration is located in exon 14 (coding exon 14) of the SPTA1 gene. This alteration results from a C to T substitution at nucleotide position 1690, causing the arginine (R) at amino acid position 564 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Genomic Medicine Center of Excellence, |
RCV003989828 | SCV004807036 | uncertain significance | Elliptocytosis 2 | 2024-03-26 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV004790523 | SCV005408180 | uncertain significance | not provided | 2024-02-28 | criteria provided, single submitter | clinical testing |